Pointers With Dr Portela: Laser Tattoo Removal
In this week’s Pointers with Dr Portela, the 208SkinDoc reviews a video of laser tattoo removal.
Patient Presentation of PsA and PsO
Drs Mark G. Lebwohl and Joseph F. Merola discuss how patient presentation differs in patients with PsO and PsA.
Pathogenesis of PsA and PsO
Mark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, discuss updates in the pathogenesis of PsA and PsO.
Addressing Patients' Concerns With Biosimilars
Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.
Clinician Confidence in Biosimilars
Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, address the importance of clinician confidence in biosimilars.
Challenges With Biosimilars Being Approved in the US
An expert rheumatologist and a dermatologist discuss challenges to bringing biosimilars to the United States.
Best Practices for Preventing Advanced BCC and the Importance of Multidisciplinary Teams
Drs Sherrif F. Ibrahim and Vishal Patel discuss the importance of a multidisciplinary team in the treatment of BCC as well as best practices for preventing advanced BCC.
Overview and Burden of BCC
Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide an overview of BCC and discuss disease burden.
Pointers With Dr Portela: Oral Minoxidil For Hair Loss
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses what patients need to know about oral minoxidil for hair loss.
Chen On Racial Disparities in CTCL
Dr Chen Discusses epidemiology and racial disparities in CTCL.
Take-home Points to Manage Acne
Drs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.
Types of Moisturizers and How to Select Them
Expert dermatologists discuss different types of moisturizers and how to properly select a moisturizer.
Deucravacitinib Approved by FDA for Treatment of Psoriasis
Deucravacitinib offers new hope for those with moderate-to-severe plaque psoriasis.
Hilary Baldwin, MD, Gets Excited About the Skin of Color Update Meeting
Hilary Baldwin, MD, discusses what's new and exciting at the Skin of Color Update Meeting in NYC
How to Switch Patients to Biosimilars
Expert rheumatologist and dermatologist, Drs Roy M. Fleischmann and Joel M. Gelfand, discuss the impact of switching patients to biosimilars.
Role of Biosimilars and Assessing Clinical Impact
Drs Roy M. Fleischmann and Joel M. Gelfand discuss the roles of biosimilars and how to assess efficacy once a patient is switched to a biosimilar.
Take-Home Points
Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
Case 3 Continued: How to Have Conversation About Risk of Biologics and Length of Therapy
Atopic dermatitis specialists discuss how to have a conversation with parents about risks of biologics and how to answer questions about length of therapy.
Case 3 Continued: Impressions
Expert pediatric dermatologists provide impressions on the case of a 12-year-old girl with atopic dermatitis.
Case 3: 12-Year-Old-Female With Atopic Dermatitis
Joshua Zeichner, MD, reviews the case of a 12-year-old girl with atopic dermatitis.
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Addressing Patients' Concerns With Biosimilars")
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Clinician Confidence in Biosimilars")
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Role of Biosimilars and Assessing Clinical Impact")
